Global Health Ventures to Develop Fast Acting Anti-Stress Medication

Global Health Ventures to Develop Fast Acting Anti-Stress Medication
VANCOUVER, BRITISH COLUMBIA–(Marketwire – May 12, 2010) – Global Health Ventures Inc. (OTCBB:GHLV) (the “Company”) is pleased to announce that, it has targeted the development of a new anti-stress medication “Relax-B” using its proprietary sublingual technology. The Company’s lead therapeutic product “X-Excite” (male sexual enhancement drug) is already proceeding successfully through the …

Read more on Marketwire

More Meth Drug Addiction Info: